|
FKBP1AP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.734000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.817600E-01 |
| Normal-vs-Stage2 |
9.004000E-01 |
| Normal-vs-Stage3 |
5.439600E-01 |
| Normal-vs-Stage4 |
2.760600E-01 |
| Stage1-vs-Stage2 |
7.989800E-01 |
| Stage1-vs-Stage3 |
5.393600E-01 |
| Stage1-vs-Stage4 |
3.134800E-01 |
| Stage2-vs-Stage3 |
5.318600E-01 |
| Stage2-vs-Stage4 |
2.851000E-01 |
| Stage3-vs-Stage4 |
6.388200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.732200E-01 |
| Normal-vs-AfricanAmerican |
6.860000E-01 |
| Normal-vs-Asian |
1.327370E-01 |
| Caucasian-vs-AfricanAmerican |
6.044200E-01 |
| Caucasian-vs-Asian |
1.691200E-01 |
| AfricanAmerican-vs-Asian |
2.180600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.404400E-01 |
| Normal-vs-Female |
2.870800E-01 |
| Male-vs-Female |
5.334200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.237000E-01 |
| Normal-vs-Extreme_Weight |
4.579400E-01 |
| Normal-vs-Obese |
3.012600E-01 |
| Normal-vs-Extreme_Obese |
6.600000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.656600E-01 |
| Normal_Weight-vs-Obese |
3.456200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.723800E-01 |
| Extreme_Weight-vs-Obese |
2.704500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.475000E-01 |
| Obese-vs-Extreme_Obese |
2.718800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.556800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.216600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.456800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.154600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.078600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.383400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.135580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.008800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.471200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.590200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.464000E-01 |
| Normal-VS-Type2 PRCC |
9.958000E-01 |
| Normal-VS-KIRP CIMP |
1.908220E-01 |
| Normal-VS-Unclassified PRCC |
2.498200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.609800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.072610E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.820100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.882650E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.780790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.180000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.561200E-01 |
| Normal-vs-N1 |
8.981400E-01 |
| Normal-vs-N2 |
1.914050E-02 |
| N0-vs-N1 |
5.029000E-01 |
| N0-vs-N2 |
8.920200E-02 |
| N1-vs-N2 |
1.478110E-02 |
|
|
